Automated And Closed Cell Therapy Processing Systems Market To Reach $3.66 Billion By 2030

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends

The global automated and closed cell therapy processing systems market size is expected to reach USD 3.66 billion by 2030, registering a CAGR of 18.2% over the forecast period, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

 Request a free sample copy or view report summary: Automated And Closed Cell Therapy Processing Systems Market Report

Automated And Closed Cell Therapy Processing Systems Market Report Highlights

• The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2022. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment

• The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs

• Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies

• The non-stem cellular therapies segment dominated the market in 2022 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment

• The pre-commercial/R&D scale segment captured the maximum revenue share in 2022 due to the increased number of research and innovation activities for new drug & therapy developments

• North America emerged as the highest revenue-generating region in 2022 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs

• Companies are undertaking strategic initiatives, such as partnerships and collaborations, to gain higher market shares. For instance, in January 2021, Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform

Automated And Closed Cell Therapy Processing Systems Market Segmentation

Grand View Research has segmented the global automated and closed cell therapy processing systems market report based on workflow, type, scale, and region:

Automated And Closed Cell Therapy Processing Systems Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Separation

• Expansion

• Apheresis

• Fill-Finish

• Cryopreservation

• Others

Automated And Closed Cell Therapy Processing Systems Type Outlook (Revenue, USD Million, 2018 - 2030)

• Stem Cell Therapy

• Non-Stem Cell Therapy

Automated And Closed Cell Therapy Processing Systems Scale Outlook (Revenue, USD Million, 2018 - 2030)

• Pre-commercial/R&D Scale

• Commercial Scale

Automated And Closed Cell Therapy Processing Systems Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Automated And Closed Cell Therapy Processing Systems Market

• MiltenyiBiotec

• Lonza

• Fresenius Kabi

• Cytiva (Danaher Corp.)

• BioSpherix, Ltd.

• Terumo Corporation

• Sartorius AG

• ThermoGenesis Holdings, Inc.

• Cellares Inc.

• Thermo Fisher Scientific, Inc.